1Simonelli C ,Spina M ,Cinelli R, et al. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single-institution study [ J ]. J Clin Oncol,2003,21 (21) :3948 - 3954.
3Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma[ J ]. Oncologist ,2007,12 (5) :569 - 576.
4Little RF, Gutierrez M, Jaffe ES, et al. HIV-associated non- Hodgkin lymphoma: Incidence, presentation, and prognosis [ J ]. JAMA,2001,285(14) : 1880 - 1885.
5Fakhari FD,Jeong JH,Kanan Y, et al. The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma [ J]. J Clin Invest, 2006,116 (3) :735 -742.
6Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphoma: A tissue-based variant of primary effusion lymphoma [ J]. J Mol Diagn,2005,7(1 ) : 17 -27.
7Matsumoto Y, Nomura K, Ueda K, et al. Human herpesvirus 8negative malignant effusion lymphoma: A distinct clinical entityand successful treatment with rituximab [ J ]. Leuk Lymphoma, 2005,46(3) :415 -419.
8Dukers NH, Rezza G. Human herpesvirus 8 epidemiology : What we do and do not know[J]. AIDS,2003,17(9) : 1717 -1730.
9Matta H, Chaudhary PM. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP) [ J] Proc Natl Acad Sci USA,2004, 101 (25) :9399 - 9404.
2Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions [J]. Mayo Clin Proc, 2008, 83(2):235-250.
3Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumors [J]. J Thorac Oncol, 2007, 2(8):706-714.
4Pass H, Carbone D, Minna J, et al. Lung Cancer: Principles and Practice[M]//Wozniak A, Gadgeel S. Clinical presentation of nonsmall cell carcinoma of the lung. Third Edition. Philadelphia: Lippincott Williams & Wilkins, 2005:291-303.
5Brimo F, Michel RP, Khetani K, et al. Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis [J]. Cancer, 2007, 111(4):224-233.
6Dubashi B, Cyriac S, Tenali SG. Clinicopathological analysis and outcome of primary mediastinal malignancies A report of 91 cases from a single institute [J]. Ann Thorac Med,2009,4(3):140-142.
7Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions [J]. Adv Anat Pathol,2009, 16(4):236-246.
8Alexandrakis MG, Passam FH, Kyriakou DS, et al. Pleural effusions in hematologic malignancies [J]. Chest, 2004, 125(4):1546-1555.
9Ferrer J, Roldán J, Teixidor J, et al. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy [J]. Chest, 2005, 127(3):1017-1022.
10Nakatsuka S, Yao M, Hoshida Y, et al. Pyothoraxassociated lymphoma: a review of 106 cases [J]. J Clin Oncol, 2002, 20(20):4255-4260.
